Tandem Diabetes Care Inc (TNDM)
R&D Expense Growth
1.94%
Quarterly · Period ending:
TNDM R&D Expense Growth
Latest reported1.94%period ending
Latest reported1.94%period ending
TNDM Quarterly R&D Growth (QoQ) (0.00% → 1.94%)
Latest values, visible window
High-resolution chart · PNG
TNDM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.9442% | |
| -0.0673% | |
| -3.7947% | |
| -0.4884% | |
| -61.6382% | |
| 140.2912% | |
| 2.1387% | |
| 3.6107% | |
| 6.6646% | |
| 8.5438% | |
| 1.5106% | |
| -2.243% | |
| -64.4918% | |
| 239.5585% | |
| -47.4917% | |
| 102.0017% | |
| 1.2394% | |
| 12.4373% | |
| 22.3633% | |
| 17.5765% | |
| 14.1306% | |
| 3.3667% | |
| 7.9657% | |
| 0.6693% | |
| 13.2464% | |
| 12.3339% | |
| 4.3944% | |
| 7.4438% | |
| 19.3311% | |
| 6.7296% | |
| 9.9762% | |
| 23.9002% | |
| 8.0502% | |
| 3.895% | |
| 17.033% | |
| 0.9864% | |
| -5.1462% | |
| 18.0939% | |
| -29.4118% | |
| 48.5756% | |
| -0.6476% | |
| 1.1648% | |
| -19.085% | |
| 31.5001% | |
| 0.2589% | |
| -1.5043% | |
| -12.9992% | |
| 21.9038% | |
| 0.9467% | |
| 9.4711% | |
| 26.2033% | |
| -3.8851% | |
| 18.7853% | |
| 16.7497% | |
| -5.7155% | |
| 0% |